Skip to main content
This block is broken or missing. You may be missing content or you might need to enable the original module.
Home

Main sub menu

  • Investors
  • Careers
    • Working at Recipharm
    • The Recipharm story
    • Meet our employees
    • Current vacancies
  • Contact
    • Contact us
    • Development services contacts
    • Manufacturing services contacts
    • Locations
      • France
        • Fontaine
        • Kaysersberg
        • Monts
        • Pessac
      • Germany
        • Monheim
        • Wasserburg
        • Zwickau
      • India
        • Bengaluru
        • Karnal / Paonta Sahib
      • Israel
        • Ness Ziona
      • Italy
        • Brescia
        • Lainate
        • Masate
        • Paderno Dugnano
        • Pianezza
      • Portugal
        • Odivelas
        • Queluz
      • Spain
        • Parets
        • Leganés
      • Sweden
        • Höganäs
        • Stockholm city (HQ)
        • Karlskoga
        • Solna
        • Stockholm
        • Strängnäs
        • Uppsala
        • Uppsala Development
      • UK
        • Ashton
        • Cramlington
        • Holmes Chapel
        • Queenborough
      • USA
        • Research Triangle Park

Main navigation

  • Development
    • Drug substance
    • Drug product
    • Analytical chemistry
    • Clinical trial material (CTM)
  • Manufacturing
    • Solids
    • Semi-solids
    • Liquids
    • Inhalation
    • Injectables
    • Ophthalmics
  • Solutions
    • Recipharm Analytical Solutions™
    • Recipharm Inhalation Solutions™
    • Recipharm Pathway to Clinic®
    • Serialisation
  • Bespak
  • Learn
  • Press & events
    • Press
    • Events
    • Reports
    • Insights
  • Our story
    • Recipharm in brief
    • Business model
    • Business overview
    • Sustainability
    • Company history

Press & events

What's happening?

Stay updated on our latest news and events.

Press and Event

  • Press
  • Events
  • Reports
  • Insights
Displaying 221 - 230 of 356

Subscribe

Press

Invitation to telephone conference due to Recipharm’s acquisition of Lusomedicamenta

2014.11.14 Read more

Press

Recipharm acquires Lusomedicamenta for SEK 1 billion

2014.11.13 Read more

Press

Interim report January-September 2014

2014.11.07 Read more

Press

Interim report January-September 2014

2014.11.07 Read more

Press

Invitation to presentation of Recipharm’s interim report for the third quarter of 2014 on 7 November

2014.11.05 Read more

Press

The main shareholders implement a division of their shareholdings in Recipharm

2014.10.17 Read more

Press

Recipharm AB's board member won Women's board Award

2014.10.16 Read more

Press

Recipharm completes acquisition of Corvette Pharmaceutical Services Group for SEK1.1 billion

2014.10.01 Read more

Press

How to implement serialization in practice

2014.09.24 Read more

Press

Recipharm secures financing for continued growth

2014.09.19 Read more

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 19
  • Page 20
  • Page 21
  • Page 22
  • Current page 23
  • Page 24
  • Page 25
  • Page 26
  • Page 27
  • …
  • Next page Next ›
  • Last page Last »

Footer menu

  • Privacy policy
  • Cookies
  • Website terms
  • T&C of sale and delivery
© 2020 Recipharm AB (publ). All rights reserved Stormfors Digitalbyrå